Literature DB >> 8993106

Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology.

S G Andrade1, J B Magalhães.   

Abstract

With the objective of establishing biological and biochemical characteristics of a significant number of Trypanosoma cruzi strains from different geographical areas, 138 strains isolated from naturally infected humans, triatomine or vertebrate hosts were studied; 120 were isolated from different areas of Brazil and 18 from other South and Central American countries. Inocula from triatomine or culture forms were injected into suckling Swiss mice, followed by passages into mice 10 to 12 g. Biological characters and histopathological study permitted the inclusion of the strains into three Types or biodemes: I, II, III. Isoenzymic analysis confirmed a correspondence between the biodemes and zymodemes: Type I and Z2b, Type II and Z2, Type III and Z1. Results showed the ubiquitary distribution of the several types of strains. The predominance of the same Type and zymodeme in one geographical area was confirmed: Type II strains among the human cases from eastern Bahia and east of Goiás; Type III strains from humans of north Brazil and Central America and from silvatic vectors or vertebrates from other geographical areas. The biological types of strains correlate with different histopathological lesions considering cardiac involvement and neuronal lesions. These findings suggest that the biological behavior together with isoenzymes patterns and pathological pictures in the vertebrate host can be an important tool for establishing correlations between strains behavior and clinico-pathological manifestations of Chagas' disease in different geographical areas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8993106     DOI: 10.1590/s0037-86821997000100006

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  35 in total

1.  Transcriptomic signatures of alterations in a myoblast cell line infected with four distinct strains of Trypanosoma cruzi.

Authors:  Daniel Adesse; Dumitru A Iacobas; Sanda Iacobas; Luciana R Garzoni; Maria de Nazareth Meirelles; Herbert B Tanowitz; David C Spray
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

2.  Infectivity for mice of Trypanosoma cruzi I and II strains isolated from different hosts.

Authors:  Marta Bértoli; Miriam Hitomi Andó; Max Jean De Ornelas Toledo; Silvana Marques De Araújo; Mônica Lúcia Gomes
Journal:  Parasitol Res       Date:  2006-01-31       Impact factor: 2.289

3.  Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.

Authors:  Ana Paula Gruendling; Miyoko Massago; Ana Paula M Teston; Wuelton M Monteiro; Edilson N Kaneshima; Silvana M Araújo; Mônica L Gomes; Maria das Graças V Barbosa; Max Jean O Toledo
Journal:  Am J Trop Med Hyg       Date:  2015-05-04       Impact factor: 2.345

4.  Infection by Trypanosoma cruzi enhances anion conductance in rat neonatal ventricular cardiomyocytes.

Authors:  Mayra Delgado-Ramírez; Igor I Pottosin; Valery Melnikov; Oxana R Dobrovinskaya
Journal:  J Membr Biol       Date:  2010-11-18       Impact factor: 1.843

5.  Trypanosoma cruzi: clones isolated from the Colombian strain, reproduce the parental strain characteristics, with ubiquitous histotropism.

Authors:  Edson Camandaroba; Torriceli S Thé; Daniel Huber Pessina; Sonia G Andrade
Journal:  Int J Exp Pathol       Date:  2006-06       Impact factor: 1.925

6.  Widespread, focal copy number variations (CNV) and whole chromosome aneuploidies in Trypanosoma cruzi strains revealed by array comparative genomic hybridization.

Authors:  Todd A Minning; D Brent Weatherly; Stephane Flibotte; Rick L Tarleton
Journal:  BMC Genomics       Date:  2011-03-07       Impact factor: 3.969

Review 7.  Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease.

Authors:  Louisa A Messenger; Michael A Miles; Caryn Bern
Journal:  Expert Rev Anti Infect Ther       Date:  2015-08       Impact factor: 5.091

8.  Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes.

Authors:  Max Jean de Ornelas Toledo; Maria Terezinha Bahia; Cláudia M Carneiro; Olindo Assis Martins-Filho; Michel Tibayrenc; Christian Barnabé; Washington Luis Tafuri; Marta de Lana
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

9.  Trypanosoma cruzi and myoid cells from seminiferous tubules: interaction and relation with fibrous components of extracellular matrix in experimental Chagas' disease.

Authors:  Luiz Otávio Pereira Carvalho; Ana Lucia Abreu-Silva; Daiana de Jesús Hardoim; Roberto Carlos Tedesco; Verônica Gonçalves Mendes; Sylvio Celso Gonçalves da Costa; Kátia da Silva Calabrese
Journal:  Int J Exp Pathol       Date:  2009-02       Impact factor: 1.925

10.  Sequence diversity and differential expression of Tc52 immuno-regulatory protein in Trypanosoma cruzi: potential implications in the biological variability of strains.

Authors:  Françoise Mathieu-Daudé; Marie-France Bosseno; Edwin Garzon; Joël Lelièvre; Denis Sereno; Ali Ouaissi; Simone Frédérique Brenière
Journal:  Parasitol Res       Date:  2007-07-23       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.